Uracil and tegafur (in a molar ratio of 4:1 [UFT]) plus calcium folinate comprise the components of the oral agent, Orzel, which appears to have activity comparable to intravenously administered 5-fluorouracil. This article
Martina Schiebe, MD
Advertisement
Articles by Martina Schiebe, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Investigators Halt Phase 3 Trial of Sacituzumab Govitecan Combo in NSCLC
2
VT-EBV-N Yields Durable Disease-Free Survival in Pretreated ENKTL
3
ASCO 2026: Translating the Top Prostate Cancer Data Into Clinical Action
4
Anbenitamab Regimen Meets Phase 3 End Points in HER2+ Breast Cancer
5